[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

TheBull_Stocks Avatar TheBull @TheBull_Stocks on x 20.9K followers Created: 2025-07-22 14:53:58 UTC

$REPL $XXXX filled a few! plummeted (-75%) $XXXXX to $XXXX on FDA response letter!

Current Cash $8.19/share

Replimune Receives Complete Response Letter from FDA for RP1 Biologics License Application for the Treatment of Advanced Melanoma.

The Company will request a Type A meeting and expects it will be granted within XX days. Replimune plans to urgently interact with the FDA to find a path forward for the timely accelerated approval

Possible Reversal Play! Manage Risks

XXXXXX engagements

Engagements Line Chart

Related Topics replimune $819share $repl

Post Link